The interaction between CD200, expressed on several cell types, and its receptor CD200R, expressed on cells of the myeloid lineage, has been shown to be an important factor in modulating inflammation in macrophage function in several conditions including colitis and arthritis. More recently its modulatory effect on microglial activation has been identified and CD200-deficiency has been associated with increased microglial activation accompanied by increased production of inflammatory cytokines. The response of glia prepared from CD200-deficient mice to stimuli like lipopolysaccharide (LPS) is markedly greater than the response of cells prepared from wildtype mice and, consistent with this, is the recent observation that expression of Toll-like receptor (TLR)4 and signalling through NFjB are increased in microglia prepared from CD200-deficient mice. Here we show that glia from CD200-deficient mice are also more responsive to interferon-c (IFNc) which triggers classical activation of microglia. We investigated the effects of CD200-deficiency in vivo and report that there is an increase in expression of several markers of microglial activation including tumor necrosis factor (TNF)-a, which is a hallmark of classically-activated microglia. These changes are accompanied by increased IFNc, and the evidence suggests that this is produced by infiltrating cells including T cells and macrophages. We propose that these cells enter the brain as a consequence of increased blood brain barrier (BBB) permeability in CD200-deficient mice and that infiltration is assisted by increased expression of the chemokines, monocyte chemotactic protein-1 (MCP-1), IFNc-induced protein-10 (IP-10) and RANTES. This may have implications in neurodegenerative diseases where BBB permeability is compromised.
Introduction
Microglia, like macrophages, are plastic cells, responding to different stimuli by adopting different morphological and functional phenotypes indicative of their broad array of functions (Lynch, 2009) . These cells are the immune cells of the brain and therefore respond to pathogen-associated, and danger-associated, molecular patterns which trigger the responses that result from insult. An acute stimulus generally induces release of inflammatory mediators, but this relatively brief inflammatory state is followed by restoration of microglia to their resting state. In contrast, exposure of cells to chronic activation is undesirable and can result in damage to neighboring cells.
A number of endogenous mechanisms ensure that microglial activation is kept in check and these include the interaction with other cells through ligand-receptor binding. Among the ligand-receptor pairs is CD200-CD200R which has complementary cell expression patterns characteristic of this method of controlling microglial activation. Thus CD200 is expressed on several cell types including neurons (Lyons et al., 2007a; Webb and Barclay, 1984) and astrocytes (Costello et al., 2011) whereas CD200R is expressed primarily on cells of the myeloid lineage and on microglia in the brain (Barclay et al., 2002; Koning et al., 2009) . The evidence has indicated that decreased expression of CD200, which occurs with age (Cox et al., 2012; Frank et al., 2006) , Ab treatment (Lyons et al., 2007a) or in the brain of AD patients (Walker et al., 2009) , is associated with the type of microglial activation that is characterized by inflammatory changes (Colton and Wilcock, 2010) . At least in some cases, these inflammatory changes are attenuated by a CD200 fusion protein (CD200Fc) which stimulates CD200R activation (Cox et al., 2012; Lyons et al., 2012) , although the evidence indicates that the reversal is incomplete.
We have recently shown that glial cells prepared from CD200 
